Jason D. Huber - Publications

Affiliations: 
West Virginia University, Morgantown, WV, United States 
Area:
Pharmacology, Neuroscience Biology

52/86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Vijikumar A, Saralkar P, Saylor SD, Sullivan PG, Huber JD, Geldenhuys WJ. Novel mitoNEET ligand NL-1 improves therapeutic outcomes in an aged rat model of cerebral ischemia/reperfusion injury. Experimental Neurology. 355: 114128. PMID 35662609 DOI: 10.1016/j.expneurol.2022.114128  0.392
2021 Saralkar P, Mdzinarishvili A, Arsiwala TA, Lee YK, Sullivan PG, Pinti MV, Hollander JM, Kelley EE, Ren X, Hu H, Simpkins J, Brown C, Hazlehurst LE, Huber JD, Geldenhuys WJ. The Mitochondrial mitoNEET Ligand NL-1 Is Protective in a Murine Model of Transient Cerebral Ischemic Stroke. Pharmaceutical Research. PMID 33982226 DOI: 10.1007/s11095-021-03046-4  0.341
2018 Hernandez A, Tan C, Plattner F, Logsdon AF, Pozo K, Yousuf MA, Singh T, Turner RC, Luke-Wold BP, Huber JD, Rosen CL, Bibb JA. Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes. Molecular Brain. 11: 64. PMID 30409147 DOI: 10.1186/S13041-018-0408-1  0.386
2017 Logsdon AF, Lucke-Wold BP, Turner RC, Li X, Adkins CE, Mohammad AS, Huber JD, Rosen CL, Lockman PR. A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior. Archives of Neuroscience. 4. PMID 28758136 DOI: 10.5812/Archneurosci.44254  0.429
2017 Turner RC, Naser ZJ, Lucke-Wold BP, Logsdon AF, Vangilder RL, Matsumoto RR, Huber JD, Rosen CL. Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells. Neuroimmunology and Neuroinflammation. 4: 6-15. PMID 28164149 DOI: 10.20517/2347-8659.2016.40  0.725
2017 Lucke-Wold BP, Logsdon A, Turner RC, Huber JD, Rosen CL. Endoplasmic Reticulum Stress Modulation as a Target for Ameliorating Effects of Blast Induced Traumatic Brain Injury. Journal of Neurotrauma. PMID 28077004 DOI: 10.1089/Neu.2016.4680  0.352
2017 Logsdon AF, Lucke-Wold BP, Rosen CL, Huber JD. Risk Factors: Aging Primer On Cerebrovascular Diseases. 162-167. DOI: 10.1016/B978-0-12-803058-5.00033-3  0.387
2016 Lucke-Wold BP, Phillips M, Turner RC, Logsdon AF, Smith KE, Huber JD, Rosen CL, Regele JD. Elucidating the role of compression waves and impact duration for generating mild traumatic brain injury in rats. Brain Injury. 1-8. PMID 27880054 DOI: 10.1080/02699052.2016.1218547  0.428
2016 Logsdon AF, Lucke-Wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber JD. Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Research. PMID 27131989 DOI: 10.1016/J.Brainres.2016.04.063  0.389
2016 Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL, Simard JM. Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review. International Journal of Molecular Sciences. 17. PMID 27049383 DOI: 10.3390/Ijms17040497  0.381
2015 Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Lee JM, Bailes JE, Dashnaw ML, Huber JD, Petraglia AL, Rosen CL. Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery. Frontiers in Neurology. 6: 223. PMID 26579067 DOI: 10.3389/Fneur.2015.00223  0.341
2015 Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith KE, Huber JD, Rosen CL, Petraglia AL. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in Neurology. 6: 222. PMID 26539159 DOI: 10.3389/Fneur.2015.00222  0.353
2015 Lucke-Wold BP, Nguyen L, Turner RC, Logsdon AF, Chen YW, Smith KE, Huber JD, Matsumoto R, Rosen CL, Tucker ES, Richter E. Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure. Seizure. 33: 13-23. PMID 26519659 DOI: 10.1016/J.Seizure.2015.10.002  0.351
2015 Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD. Amelioration of nicotinamide adenine dinucleotide phosphate-mediated stress reduces cell death after blast-induced traumatic brain injury. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 26414010 DOI: 10.1016/J.Trsl.2015.08.005  0.382
2015 Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ, Omalu BI, Huber JD, Rosen CL. Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. Journal of Neurosurgery. 1-16. PMID 26381255 DOI: 10.3171/2015.3.Jns141802  0.351
2015 Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD. Bryostatin extends tPA time window to 6h following middle cerebral artery occlusion in aged female rats. European Journal of Pharmacology. 764: 404-412. PMID 26189021 DOI: 10.1016/J.Ejphar.2015.07.035  0.398
2015 Logsdon AF, Lucke-Wold BP, Turner RC, Huber JD, Rosen CL, Simpkins JW. Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury. Comprehensive Physiology. 5: 1147-60. PMID 26140712 DOI: 10.1002/Cphy.C140057  0.47
2015 Lucke-Wold BP, Turner RC, Logsdon AF, Simpkins JW, Alkon DL, Smith KE, Chen YW, Tan Z, Huber JD, Rosen CL. Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration. Journal of Alzheimer's Disease : Jad. 43: 711-24. PMID 25114088 DOI: 10.3233/Jad-141422  0.456
2014 VanGilder RL, Huber JD. Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction. Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs. 2: 13-22. PMID 28781979 DOI: 10.14304/Surya.Jpr.V2N7.2  0.737
2014 Logsdon AF, Lucke-Wold BP, Rosen CL, Huber JD. Disparity among neural injury models and the unfolded protein response. Journal of Neurological Disorders & Stroke. 2. PMID 27284579  0.313
2014 Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE, Matsumoto RR, Huber JD, Rosen CL. Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in Cellular Neuroscience. 8: 421. PMID 25540611 DOI: 10.3389/Fncel.2014.00421  0.391
2014 Lucke-Wold BP, Logsdon AF, Turner RC, Rosen CL, Huber JD. Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease. Advances in Pharmacology (San Diego, Calif.). 71: 411-49. PMID 25307225 DOI: 10.1016/Bs.Apha.2014.07.001  0.467
2014 Lucke-Wold BP, Logsdon AF, Smith KE, Turner RC, Alkon DL, Tan Z, Naser ZJ, Knotts CM, Huber JD, Rosen CL. Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain Injury. Molecular Neurobiology. PMID 25301233 DOI: 10.1007/S12035-014-8902-7  0.421
2014 Tan Z, Li X, Turner RC, Logsdon AF, Lucke-Wold B, DiPasquale K, Jeong SS, Chen R, Huber JD, Rosen CL. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats. European Journal of Pharmacology. 738: 368-73. PMID 24933645 DOI: 10.1016/J.Ejphar.2014.05.052  0.315
2014 Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb JA. Ischemic stroke injury is mediated by aberrant Cdk5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8259-67. PMID 24920629 DOI: 10.1523/Jneurosci.4368-13.2014  0.433
2014 Lucke-Wold BP, Turner RC, Logsdon AF, Bailes JE, Huber JD, Rosen CL. Linking traumatic brain injury to chronic traumatic encephalopathy: Identification of potential mechanisms leading to neurofibrillary tangle development Journal of Neurotrauma. 31: 1129-1138. PMID 24499307 DOI: 10.1089/Neu.2013.3303  0.426
2014 Turner RC, VanGilder RL, Naser ZJ, Lucke-Wold BP, Bailes JE, Matsumoto RR, Huber JD, Rosen CL. Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment? Neurosurgery. 74: 382-94; discussion 3. PMID 24448183 DOI: 10.1227/Neu.0000000000000292  0.735
2014 VanGilder RL, Davidov DM, Stinehart KR, Huber JD, Turner RC, Wilson KS, Haney E, Davis SM, Chantler PD, Theeke L, Rosen CL, Crocco TJ, Gutmann L, Barr TL. C-reactive protein and long-term ischemic stroke prognosis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 21: 547-53. PMID 24211144 DOI: 10.1016/J.Jocn.2013.06.015  0.723
2013 Tan Z, Turner RC, Leon RL, Li X, Hongpaisan J, Zheng W, Logsdon AF, Naser ZJ, Alkon DL, Rosen CL, Huber JD. Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke. Stroke; a Journal of Cerebral Circulation. 44: 3490-7. PMID 24172582 DOI: 10.1161/Strokeaha.113.002411  0.489
2013 Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental Neurology. 248: 520-9. PMID 23876514 DOI: 10.1016/J.Expneurol.2013.07.008  0.382
2013 Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental Neurology. 247: 134-42. PMID 23631864 DOI: 10.1016/J.Expneurol.2013.04.009  0.306
2013 Turner RC, Lucke-Wold B, Lucke-Wold N, Elliott AS, Logsdon AF, Rosen CL, Huber JD. Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. International Journal of Molecular Sciences. 14: 1890-917. PMID 23344061 DOI: 10.3390/Ijms14011890  0.412
2013 Turner RC, Dodson SC, Rosen CL, Huber JD. The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. Journal of Neurosurgery. 118: 1072-85. PMID 23331000 DOI: 10.3171/2012.11.Jns12408  0.406
2012 Turner RC, Seminerio MJ, Naser ZJ, Ford JN, Martin SJ, Matsumoto RR, Rosen CL, Huber JD. Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease. Journal of Neurosurgery. 117: 629-37. PMID 22746378 DOI: 10.3171/2012.5.Jns112224  0.31
2012 Leon RL, Li X, Huber JD, Rosen CL. Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol. Endocrinology. 153: 3386-93. PMID 22581460 DOI: 10.1210/En.2011-1859  0.386
2012 VanGilder RL, Huber JD, Rosen CL, Barr TL. The transcriptome of cerebral ischemia. Brain Research Bulletin. 88: 313-9. PMID 22381515 DOI: 10.1016/J.Brainresbull.2012.02.002  0.734
2011 Leon RL, Huber JD, Rosen CL. Potential age-dependent effects of estrogen on neural injury. The American Journal of Pathology. 178: 2450-60. PMID 21641373 DOI: 10.1016/J.Ajpath.2011.01.057  0.353
2011 Vangilder RL, Rosen CL, Barr TL, Huber JD. Targeting the neurovascular unit for treatment of neurological disorders. Pharmacology & Therapeutics. 130: 239-47. PMID 21172386 DOI: 10.1016/J.Pharmthera.2010.12.004  0.714
2010 Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD, O'Callaghan JP. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience. 170: 633-44. PMID 20633608 DOI: 10.1016/J.Neuroscience.2010.07.011  0.438
2010 Popa-Wagner A, Pirici D, Petcu EB, Mogoanta L, Buga AM, Rosen CL, Leon R, Huber J. Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents. Current Neurovascular Research. 7: 251-67. PMID 20590524 DOI: 10.2174/156720210792231813  0.463
2009 Kelly KA, Li X, Tan Z, VanGilder RL, Rosen CL, Huber JD. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Research. 1292: 165-72. PMID 19635468 DOI: 10.1016/J.Brainres.2009.07.052  0.756
2009 VanGilder RL, Kelly KA, Chua MD, Ptachcinski RL, Huber JD. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Experimental Brain Research. 197: 23-34. PMID 19565232 DOI: 10.1007/S00221-009-1866-6  0.738
2009 Tan Z, Li X, Kelly KA, Rosen CL, Huber JD. Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion. Brain Research. 1281: 84-90. PMID 19465008 DOI: 10.1016/J.Brainres.2009.05.042  0.387
2008 DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiology of Aging. 29: 753-64. PMID 17241702 DOI: 10.1016/J.Neurobiolaging.2006.12.007  0.44
2006 Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2660-8. PMID 16951046 DOI: 10.1152/Ajpheart.00489.2006  0.749
2006 Huber JD, Campos CR, Mark KS, Davis TP. Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 290: H732-40. PMID 16199477 DOI: 10.1152/Ajpheart.00747.2005  0.386
2005 Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. American Journal of Physiology. Heart and Circulatory Physiology. 289: H738-43. PMID 15792985 DOI: 10.1152/Ajpheart.01288.2004  0.379
2004 Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Research. 1027: 48-58. PMID 15494156 DOI: 10.1016/J.Brainres.2004.08.043  0.353
2004 Hau VS, Huber JD, Campos CR, Davis RT, Davis TP. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Research. 1018: 257-64. PMID 15276886 DOI: 10.1016/J.Brainres.2004.05.081  0.366
2004 Mark KS, Burroughs AR, Brown RC, Huber JD, Davis TP. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. American Journal of Physiology. Heart and Circulatory Physiology. 286: H174-80. PMID 12958038 DOI: 10.1152/Ajpheart.00669.2002  0.356
2003 Egleton RD, Campos CC, Huber JD, Brown RC, Davis TP. Differential effects of diabetes on rat choroid plexus ion transporter expression. Diabetes. 52: 1496-501. PMID 12765962 DOI: 10.2337/Diabetes.52.6.1496  0.34
2001 Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends in Neurosciences. 24: 719-25. PMID 11718877 DOI: 10.1016/S0166-2236(00)02004-X  0.321
Low-probability matches (unlikely to be authored by this person)
2014 Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental Neurology. 254: 180-9. PMID 24508558 DOI: 10.1016/J.Expneurol.2014.01.020  0.297
2002 Huber JD, Hau VS, Mark KS, Brown RC, Campos CR, Davis TP. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. European Journal of Pharmacology. 450: 297-304. PMID 12208323 DOI: 10.1016/S0014-2999(02)02150-7  0.296
2014 Elliott AS, Huber JD, O'Callaghan JP, Rosen CL, Miller DB. A review of sleep deprivation studies evaluating the brain transcriptome. Springerplus. 3: 728. PMID 25932362 DOI: 10.1186/2193-1801-3-728  0.284
2008 Huber JD. Diabetes, cognitive function, and the blood-brain barrier. Current Pharmaceutical Design. 14: 1594-600. PMID 18673200 DOI: 10.2174/138161208784705441  0.282
2016 Nguyen L, Lucke-Wold BP, Logsdon AF, Scandinaro AL, Huber JD, Matsumoto RR. Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice. Neuroreport. 27: 1004-11. PMID 27580401 DOI: 10.1097/Wnr.0000000000000646  0.279
2015 Lucke-Wold BP, Smith KE, Nguyen L, Turner RC, Logsdon AF, Jackson GJ, Huber JD, Rosen CL, Miller DB. Sleep disruption and the sequelae associated with traumatic brain injury. Neuroscience and Biobehavioral Reviews. 55: 68-77. PMID 25956251 DOI: 10.1016/J.Neubiorev.2015.04.010  0.278
2020 Logsdon AF, Lucke-Wold BP, Turner RC, Collins SM, Reeder EL, Huber JD, Rosen CL, Robson MJ, Plattner F. Low-intensity Blast Wave Model for Preclinical Assessment of Closed-head Mild Traumatic Brain Injury in Rodents. Journal of Visualized Experiments : Jove. PMID 33226021 DOI: 10.3791/61244  0.276
2005 Witt KA, Mark KS, Huber J, Davis TP. Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. Journal of Neurochemistry. 92: 203-14. PMID 15606909 DOI: 10.1111/J.1471-4159.2004.02871.X  0.276
2014 Lucke-Wold BP, DiPasquale K, Logsdon AF, Nguyen L, Lucke-Wold AN, Turner RC, Huber JD, Rosen CL. Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke. American Medical Student Research Journal. 1: 29-38. PMID 27284575 DOI: 10.15422/amsrj.2014.05.004  0.267
2015 Matsumoto R, Robson M, Turner R, Naser Z, Kaushal N, McCurdy C, Huber J, O’Callaghan J. Attenuation of methamphetamine-induced striatal neurotoxicity involves both neuronal and glial mechanisms Drug and Alcohol Dependence. 146: e197. DOI: 10.1016/J.Drugalcdep.2014.09.452  0.266
2016 Turner RC, DiPasquale K, Logsdon AF, Tan Z, Naser ZJ, Huber JD, Rosen CL, Lucke-Wold BP. The role for infarct volume as a surrogate measure of functional outcome following ischemic stroke. Journal of Systems and Integrative Neuroscience. 2. PMID 28299202  0.266
2002 Huber JD, Hau VS, Borg L, Campos CR, Egleton RD, Davis TP. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 283: H1531-7. PMID 12234806 DOI: 10.1152/Ajpheart.00027.2002  0.265
2017 Gao F, Lucke-Wold BP, Li X, Logsdon AF, Xu LC, Xu S, LaPenna KB, Wang H, Talukder MAH, Siedlecki CA, Huber JD, Rosen CL, He P. Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation. Frontiers in Physiology. 8: 1124. PMID 29367846 DOI: 10.3389/Fphys.2017.01124  0.265
2001 Huber JD, Witt KA, Hom S, Egleton RD, Mark KS, Davis TP. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology. Heart and Circulatory Physiology. 280: H1241-8. PMID 11179069 DOI: 10.1152/Ajpheart.2001.280.3.H1241  0.257
2012 Lucke-Wold BP, Turner RC, Lucke-Wold AN, Rosen CL, Huber JD. Age and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic stroke. The Yale Journal of Biology and Medicine. 85: 523-39. PMID 23239952  0.25
2011 Seminerio MJ, Kaushal N, Shaikh J, Huber JD, Coop A, Matsumoto RR. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice. Pharmacology, Biochemistry, and Behavior. 98: 12-20. PMID 21130800 DOI: 10.1016/J.Pbb.2010.11.023  0.246
2003 Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR, Davis TP. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. Journal of Cell Science. 116: 693-700. PMID 12538770 DOI: 10.1242/Jcs.00264  0.24
2003 Wolka AM, Huber JD, Davis TP. Pain and the blood-brain barrier: obstacles to drug delivery. Advanced Drug Delivery Reviews. 55: 987-1006. PMID 12935941 DOI: 10.1016/S0169-409X(03)00100-5  0.229
2001 Hom S, Egleton RD, Huber JD, Davis TP. Effect of reduced flow on blood-brain barrier transport systems. Brain Research. 890: 38-48. PMID 11164767 DOI: 10.1016/S0006-8993(00)03027-4  0.222
2013 Wu-Pong S, Gobburu J, O'Barr S, Shah K, Huber J, Weiner D. The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group. American Journal of Pharmaceutical Education. 77: S2. PMID 23716757 DOI: 10.5688/Ajpe774S2  0.193
2002 Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP. Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. Journal of Pharmaceutical Sciences. 91: 2140-9. PMID 12226841 DOI: 10.1002/Jps.10202  0.182
2000 Egleton RD, Mitchell SA, Huber JD, Janders J, Stropova D, Polt R, Yamamura HI, Hruby VJ, Davis TP. Improved bioavailability to the brain of glycosylated Met-enkephalin analogs. Brain Research. 881: 37-46. PMID 11033091 DOI: 10.1016/S0006-8993(00)02794-3  0.177
2001 Witt KA, Gillespie TJ, Huber JD, Egleton RD, Davis TP. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides. 22: 2329-43. PMID 11786210 DOI: 10.1016/S0196-9781(01)00537-X  0.177
2014 Elliott AS, Huber JD, O’Callaghan JP, Rosen CL, Miller DB. A review of sleep deprivation studies evaluating the brain transcriptome Springerplus. 3. DOI: 10.1186/2193-1801-3-728  0.152
2015 Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats European Journal of Pharmacology. 764: 404-412. DOI: 10.1016/j.ejphar.2015.07.035  0.148
2018 Ruggiero SA, Huber J, Murrant CL, Brunt KR, Simpson JA. Splenic blood-flow response following myocardial infarction in rat. Canadian Journal of Physiology and Pharmacology. PMID 30102865 DOI: 10.1139/cjpp-2018-0134  0.127
2021 Hernandez A, Tan C, Plattner F, Logsdon AF, Pozo K, Yousuf MA, Singh T, Turner RC, Lucke-Wold BP, Huber JD, Rosen CL, Bibb JA. Correction to: Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes. Molecular Brain. 14: 164. PMID 34758856 DOI: 10.1186/s13041-021-00872-w  0.1
2001 Huber JD, Darling SF, Park KK, Soliman KF. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity. Pharmacology, Biochemistry, and Behavior. 69: 451-9. PMID 11509204 DOI: 10.1016/S0091-3057(01)00521-4  0.09
2000 Witt KA, Slate CA, Egleton RD, Huber JD, Yamamura HI, Hruby VJ, Davis TP. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin. Journal of Neurochemistry. 75: 424-35. PMID 10854288 DOI: 10.1046/J.1471-4159.2000.0750424.X  0.09
2003 Huber JD, Campos CR, Egleton RD, Witt K, Guo L, Roberts MJ, Bentley MD, Davis TP. Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. Journal of Pharmaceutical Sciences. 92: 1377-85. PMID 12820142 DOI: 10.1002/Jps.10406  0.077
2023 Newton E, Starcovic SA, Menze M, Konkle ME, Long TE, Hazlehurst LA, Huber JD, Robart AR, Geldenhuys WJ. Development of a fluorescence screening assay for binding partners of the iron-sulfur mitochondrial protein mitoNEET. Bioorganic & Medicinal Chemistry Letters. 129310. PMID 37137430 DOI: 10.1016/j.bmcl.2023.129310  0.076
2002 Witt KA, Huber JD, Egleton RD, Davis TP. Pluronic p85 block copolymer enhances opioid peptide analgesia. The Journal of Pharmacology and Experimental Therapeutics. 303: 760-7. PMID 12388663 DOI: 10.1124/Jpet.102.039545  0.058
1999 Kehayova PD, Bokinsky GE, Huber JD, Jain A. A caged hydrophobic inhibitor of carbonic anhydrase II. Organic Letters. 1: 187-8. PMID 10822559 DOI: 10.1021/Ol990526S  0.035
2000 Kuwahara RT, Huber JD, Ray SH. Surgical pearl: forceps method for freezing benign lesion. Journal of the American Academy of Dermatology. 43: 306-7. PMID 10906655 DOI: 10.1067/MJD.2000.106371  0.01
Hide low-probability matches.